Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

T0300000

Testosterone propionate

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

17β-hydroxy-4-androstène-3-one 17-propionate, 4-androstène même-17β-ol-3-one 17-propionate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C22H32O3
Numéro CAS:
57-85-2
Poids moléculaire :
344.49
Numéro Beilstein :
3221760
Numéro MDL:
MFCD00003653
Code UNSPSC :
41116107
ID de substance PubChem :
329826601
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

testosterone

Fabricant/nom de marque

EDQM

Contrôle du médicament

USDEA Schedule I

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

[H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]4(C)[C@H](CC[C@@]24[H])OC(=O)CC

InChI

1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1

Clé InChI

PDMMFKSKQVNJMI-BLQWBTBKSA-N

Informations sur le gène

human ... AR(367)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Testosterone propionate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

T0100000

Testosterone, European Pharmacopoeia (EP) Reference Standard

T0240000

Testosterone decanoate, European Pharmacopoeia (EP) Reference Standard

T0250000

Testosterone enantate, European Pharmacopoeia (EP) Reference Standard

T0210000

Testosterone caproate, European Pharmacopoeia (EP) Reference Standard

T0260000

Testosterone isocaproate, European Pharmacopoeia (EP) Reference Standard

Y0000696

Testosterone decanoate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0000716

Testosterone isocaproate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001312

Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard

Y0001317

Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001313

Testosterone enantate impurity H, European Pharmacopoeia (EP) Reference Standard

Y0001409

Testosterone propionate, European Pharmacopoeia (EP) Reference Standard

1649007

Testosterone propionate, United States Pharmacopeia (USP) Reference Standard

1647001

Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard

1648004

Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard

1646031

Testosterone Related Compound C, United States Pharmacopeia (USP) Reference Standard

1646097

Testosterone Related Compound I, United States Pharmacopeia (USP) Reference Standard

BP702

Testosterone propionate, British Pharmacopoeia (BP) Reference Standard

1646010

Testosterone Related Compound A CIII, United States Pharmacopeia (USP) Reference Standard

BP319

Testosterone decanoate, British Pharmacopoeia (BP) Reference Standard

BP321

Testosterone isocaproate, British Pharmacopoeia (BP) Reference Standard

BP1076

Testosterone, British Pharmacopoeia (BP) Reference Standard

1647012

Testosterone Cypionate Related Compound A, United States Pharmacopeia (USP) Reference Standard

PHR2026

Testosterone propionate, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2027

Testosterone, Pharmaceutical Secondary Standard; Certified Reference Material

1647023

Testosterone Cypionate Related Compound B, United States Pharmacopeia (USP) Reference Standard

Y0002163

Testosterone, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002174

Testosterone, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002145

Testosterone impurity I, CRS, European Pharmacopoeia (EP) Reference Standard

PHR9196

5α-Androstan-17β-ol-3-one, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

Pictogrammes

Health hazardExclamation markEnvironment
GHS08,GHS07,GHS09

Mention d'avertissement

Danger

Mentions de danger

H302,H351,H360FD,H400

Classification des risques

Acute Tox. 4 Oral - Aquatic Acute 1 - Carc. 2 - Repr. 1A

Code de la classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 3

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 4

1 of 4

Stanozolol European Pharmacopoeia (EP) Reference Standard

S1250000

Stanozolol

Testosterone enanthate analytical standard

Supelco

T3006

Testosterone enanthate

Testosterone purum, ≥99.0% (HPLC)

Sigma-Aldrich

86500

Testosterone

Testosterone European Pharmacopoeia (EP) Reference Standard

T0100000

Testosterone

Kirsten Hogg et al.
Endocrinology, 153(1), 450-461 (2011-11-17)
One of the hallmarks of polycystic ovary syndrome (PCOS) is increased ovarian androgen secretion that contributes to the ovarian, hormonal, and metabolic features of this condition. Thecal cells from women with PCOS have an enhanced capacity for androgen synthesis. To
Rui Cui et al.
Experimental gerontology, 47(1), 67-76 (2011-11-15)
Testosterone has been shown to affect motor behavior and nigrostriatal dopaminergic (NSDA) system in young and adult male rats. However, it is not known whether exogenous testosterone intervention to aged male rats can ameliorate age-related motor impairment. Thus, in the
Guo-liang Zhang et al.
Behavioural brain research, 252, 388-395 (2013-06-13)
Aging is usually associated with a progressive disruption of the redox balance leading to recurrent damage resulting from oxidative stress. Oxidative stress resulting from excessive free-radical release is likely implicated in the initiation and progression of motor behavior disorders. Therefore
Mick Rae et al.
PloS one, 8(2), e56263-e56263 (2013-03-05)
Using an ovine model of polycystic ovary syndrome (PCOS), (pregnant ewes injected with testosterone propionate (TP) (100 mg twice weekly) from day (d)62 to d102 of d147 gestation (maternal injection - MI-TP)), we previously reported female offspring with normal glucose
Todd J Brown et al.
Restorative neurology and neuroscience, 31(2), 169-176 (2012-12-19)
To investigate the effects of the androgen testosterone propionate (TP), on regeneration of the recurrent laryngeal nerve (RLN) after unilateral crush injury using assessment of vocal fold mobility (VFM) as a measure of behavioral recovery. 48 adult male rats underwent
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique